The SFDA has recently developed two new guideline documents to assist pharmaceutical manufacturers in registering their products in Saudi Arabia.

In 2018 the SFDA introduced a new track-and-trace system to monitor all human pharmaceutical products that are manufactured in Saudi Arabia and imported from abroad

As part of efforts to improve its services, the SFDA is introducing measures to make information about pharmaceutical products more accessible to patients and the health care industry